Atom Investors’s Cullinan Therapeutics CGEM Stock Holding History
Bought
Maintained
Sold
Other funds holding CGEM
Atom Investors's CGEM Position: Q2 2023 in Review
Atom Investors sold out of Cullinan Therapeutics (CGEM) in Q2 2023, closing a stake of 120,109 shares — an estimated $1.23M sold.
Atom Investors first reported a position in CGEM in Q2 2022 and held it in 4 quarters. The position peaked at $1.24M in Q2 2022. 106 funds tracked by Wall St. Rank hold CGEM as of Q2 2023.
- Atom Investors reported no remaining Cullinan Therapeutics position as of Q2 2023 after selling out during the quarter.
- Atom Investors sold 120,109 Cullinan Therapeutics shares in Q2 2023, an estimated $1.23M.
- Atom Investors first reported a position in Cullinan Therapeutics in Q2 2022 and held it in 4 quarters.
- Atom Investors's Cullinan Therapeutics position peaked at $1.24M in Q2 2022.
- 106 funds tracked by Wall St. Rank held Cullinan Therapeutics as of Q2 2023.
Based on Atom Investors's 13F filing for Q2 2023, filed 14 Aug 2023.